Schedule 13G ownership disclosure
CONATUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 20600T108
Event date: 2017-05-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 1.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-033096
- Form type
- SC 13G
- Filer
- Histogen Inc.
- CIK
- CIK 1383701
- Filed
- Feb 06, 2018
- Reporting period
- May 11, 2017
- Description
- Schedule 13G beneficial ownership